25 results for “hypercholesterolemia”. Showing 25 of 39,449.
Identifying Familial Hypercholesterolemia Using a Blood Donor Screening Program With More Than 1 Million Volunteer Donors.
hypercholesterolemia is an autosomal-dominant disorder that often causes premature
Update on genetics of familial hypercholesterolemia.
hypercholesterolemia is a monogenic Mendelian disorder characterized by elevated LDL cholesterol
Hypercholesterolemia drives microglial dysfunction and weakens response to amyloid plaques.
hypercholesterolemia. Our findings demonstrate that hypercholesterolemia suppresses microglial responses to Aβ plaques
27-hydroxycholesterol promotes oligodendrocyte maturation: Implications for hypercholesterolemia-associated brain white matter changes.
hypercholesterolemia and neurodegenerative diseases since unlike peripheral cholesterol, 27-OH is transported
[The role of hypercholesterolemia in the outbreak of Alzheimer's disease and the treatment effect of Sibraea angustata extract].
hypercholesterolemia in the outbreak of Alzheimer's disease (AD) and the treatment
Depletion of Hepatic SREBP2 Protects Against Hypercholesterolemia and Atherosclerosis through the ANGPTL3-LPL Axis.
hypercholesterolemia and atherosclerosis, in which atherosclerotic lesions are reduced by 45% compared
Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia
hypercholesterolemia, suggesting either an autosomal recessive disorder or a de novo
Large subcutaneous multi-xanthoma in familial hypercholesterolemia
hypercholesterolemia. Li YF(1), Huang Y(1), Wang NN(2), Li YX(3), Feng
Endothelial Acid Sphingomyelinase Promotes NLRP3 Inflammasome and Neointima Formation During Hypercholesterolemia.
hypercholesterolemia via MR redox signaling platforms to produce superoxide, which
Hepatocyte-Specific Knockout of YAP Protects Against Atherosclerosis via Inhibition of ANGPTL3 in Mice.
hypercholesterolemia. It is essential to seek new lipid-lowering targets
The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification.
Hypercholesterolemia (FH) Variant Curation Expert Panel was tasked with optimizing
Large subcutaneous multi-xanthoma in familial hypercholesterolemia
hypercholesterolemia. Li YF(1), Huang Y(1), Wang NN(2), Li YX(3), Feng
Beyond cardiovascular risk: Implications of Familial hypercholesterolemia on cognition and brain function.
hypercholesterolemia (FH) is a metabolic condition caused mainly by a mutation
Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993-2020.
hypercholesterolemia (ADH) in Norway. METHODS: We have extracted data from
Hypercholesterolemia Duration and Brain Area Determine Inflammatory Response Intensity and Apoptotic Mediator Activation in Apo E-/-/LDLR-/- Double-Knockout Mice.
Hypercholesterolemia (Hch) is a risk factor for cerebrovascular and neurodegenerative
Impact of age, hypercholesterolemia, and the vitamin D receptor on brain endogenous β-amyloid peptide accumulation in mice.
hypercholesterolemia, and vitamin D deficiency are risk factors that increase
Oxymatrine impedes Alzheimer's progression via the attenuation of hypercholesterolemia and fibrosis.
hypercholesterolemia and fibrosis, which contribute to cognitive impairment in AD. The research
HEG1 Protects Against Atherosclerosis by Regulating Stable Flow-Induced KLF2/4 Expression in Endothelial Cells.
hypercholesterolemia either for 2 weeks with partial carotid ligation or 2 months
The Causal Pivot: A structural approach to genetic heterogeneity and variant discovery in complex diseases.
hypercholesterolemia (HC, low-density lipoprotein cholesterol ≥4.9 mmol/L; nc = 24,656), breast
Synergistic effects of mutation and glycosylation on disease progression.
hypercholesterolemia, and Alzheimer's disease, respectively. Additionally, physiological states and aging
Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.
hypercholesterolemia. All of these can be characterized by vascular pathology
Mir147 Limits the Contribution of Non-Foamy Macrophages to Atherosclerosis.
Hypercholesterolemia and a high-fat diet promote 2 macrophage subtypes
News on the molecular regulation and function of hepatic low-density lipoprotein receptor and LDLR-related protein 1.
hypercholesterolemia in human. In addition, LRP1 controls cellular cholesterol efflux
Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development.
hypercholesterolemia (40%), hypertriglyceridemia (20%), metabolic syndrome (20%), hepatobiliary disorder (15%), endocrine/metabolic
APOE gene variants in primary dyslipidemia.
hypercholesterolemia (ADH). ADH is characterized by elevated LDL-cholesterol levels